Europe Cannabidiol Market - 2024-2031
Europe Cannabidiol Market reached in and is expected to reach by , growing with a CAGR of 18.80% during the forecast period 2026-.
The Europe Cannabidiol Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Europe Cannabidiol Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Type
Both primary and secondary data sources have been used in the global Europe Cannabidiol Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Europe Cannabidiol Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Europe Cannabidiol Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Type
- Isolate*
- Full Spectrum
- Broad spectrum
- Others
- Marijuana*
- Hemp
- Therapeutic Grade*
- Clinical Grade
- Food Grade
- Pharmaceutical*
- Food & Beverages
- Personal Care & Cosmetics
- Others
- Retail Pharmacies*
- Hospital Pharmacies
- Online Stores
- Others
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Europe Cannabidiol Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing demand for cannabidiol products
4.1.1.2. Rising legalization and products approvals
4.1.2. Restraints:
4.1.2.1. Stringent regulatory rules for cannabidiol products
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Isolate*
7.2.1. Introduction
7.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.3. Full Spectrum
7.4. Broad spectrum
7.5. Others
8. BY SOURCE
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
8.1.2. Market Attractiveness Index, By Source
8.2. Marijuana*
8.2.1. Introduction
8.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Hemp
9. BY GRADE
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
9.1.2. Market Attractiveness Index, By Grade
9.2. Therapeutic Grade*
9.2.1. Introduction
9.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.3. Clinical Grade
9.4. Food Grade
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Pharmaceutical*
10.2.1. Introduction
10.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
10.3. Food & Beverages
10.4. Personal Care & Cosmetics
10.5. Others
11. BY DISTRIBUTION CHANNEL
11.1. Introduction
11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
11.1.2. Market Attractiveness Index, By Distribution Channel
11.2. Retail Pharmacies*
11.2.1. Introduction
11.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
11.3. Hospital Pharmacies
11.4. Online Stores
11.5. Others
12. BY COUNTRY
12.1. Introduction
12.1.1. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Country
12.1.2. Market Attractiveness Index, By Country
12.2. Germany
12.2.1. Introduction
12.2.2. Key Country-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.3. The U.K.
12.3.1. Introduction
12.3.2. Key Country-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.4. France
12.4.1. Introduction
12.4.2. Key Country-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.5. Italy
12.5.1. Introduction
12.5.2. Key Country-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.6. Spain
12.6.1. Introduction
12.6.2. Key Country-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.7. Rest of Europe
12.7.1. Introduction
12.7.2. Key Country-Specific Dynamics
12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
13. COMPETITIVE LANDSCAPE
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Product Benchmarking
14. COMPANY PROFILES
14.1. Akanda Corporation. *
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Aurora Cannabis Inc.
14.3. Aphria Inc.
14.4. ENDOCA
14.5. Elixinol
14.6. Folium Biosciences
14.7. NuLeaf Naturals LLC
14.8. Cannoid LLC
14.9. Isodiol International Inc.
14.10. Medical Marijuana Inc.(*LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing demand for cannabidiol products
4.1.1.2. Rising legalization and products approvals
4.1.2. Restraints:
4.1.2.1. Stringent regulatory rules for cannabidiol products
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Isolate*
7.2.1. Introduction
7.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.3. Full Spectrum
7.4. Broad spectrum
7.5. Others
8. BY SOURCE
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
8.1.2. Market Attractiveness Index, By Source
8.2. Marijuana*
8.2.1. Introduction
8.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Hemp
9. BY GRADE
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
9.1.2. Market Attractiveness Index, By Grade
9.2. Therapeutic Grade*
9.2.1. Introduction
9.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.3. Clinical Grade
9.4. Food Grade
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Pharmaceutical*
10.2.1. Introduction
10.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
10.3. Food & Beverages
10.4. Personal Care & Cosmetics
10.5. Others
11. BY DISTRIBUTION CHANNEL
11.1. Introduction
11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
11.1.2. Market Attractiveness Index, By Distribution Channel
11.2. Retail Pharmacies*
11.2.1. Introduction
11.2.2. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
11.3. Hospital Pharmacies
11.4. Online Stores
11.5. Others
12. BY COUNTRY
12.1. Introduction
12.1.1. Market Size Analysis, USUS$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Country
12.1.2. Market Attractiveness Index, By Country
12.2. Germany
12.2.1. Introduction
12.2.2. Key Country-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.3. The U.K.
12.3.1. Introduction
12.3.2. Key Country-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.4. France
12.4.1. Introduction
12.4.2. Key Country-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.5. Italy
12.5.1. Introduction
12.5.2. Key Country-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.6. Spain
12.6.1. Introduction
12.6.2. Key Country-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.7. Rest of Europe
12.7.1. Introduction
12.7.2. Key Country-Specific Dynamics
12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
13. COMPETITIVE LANDSCAPE
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Product Benchmarking
14. COMPANY PROFILES
14.1. Akanda Corporation. *
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Aurora Cannabis Inc.
14.3. Aphria Inc.
14.4. ENDOCA
14.5. Elixinol
14.6. Folium Biosciences
14.7. NuLeaf Naturals LLC
14.8. Cannoid LLC
14.9. Isodiol International Inc.
14.10. Medical Marijuana Inc.(*LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
